The Effect of Remote Ischemic Preconditioning in Living Donor Hepatectomy
NCT03386435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160
Last updated 2019-08-19
Summary
Liver transplantation is the gold standard treatment for patients with end-stage liver disease. Despite its outstanding success, liver transplantation still entails certain complications including ischemia-reperfusion injury. Remote ischemic preconditioning is a novel and simple therapeutic method to lessen the harmful effects of ischemia-reperfusion injury, however, the majority of remote ischemic preconditioning studies on hepatic ischemia-reperfusion injury have been animal studies. Therefore, our aim was to assess the effects of remote ischemic preconditioning on postoperative liver function in living donor hepatectomy.
Conditions
- Tissue Donors
- Liver Transplantation
- Ischemia Reperfusion Injury
Interventions
- PROCEDURE
-
remote ischemic preconditioning
Remote ischemic preconditioning was performed following anesthesia induction in donors. The protocol involves 3 cycles of 5-minute inflation of a blood pressure cuff to 200 mm Hg to one upper arm, followed by 5-minute reperfusion with the cuff deflated
Sponsors & Collaborators
-
Asan Medical Center
lead OTHER
Principal Investigators
-
Jun-Gol Song, Ph.D. · Asan Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-22
- Primary Completion
- 2017-08-31
- Completion
- 2017-10-30
Countries
- South Korea
Study Locations
More Related Trials
-
Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation
NCT03563404 ·Status: COMPLETED
-
Application of in Vivo Splitting Technique in Adult Liver Transplantation
NCT06925828 ·Status: ACTIVE_NOT_RECRUITING
-
Portal Pressure Effects of Phlebotomy Combined to Vasopressin Use in Cirrhotic Patients Undergoing Liver Transplantation
NCT04472312 ·Status: COMPLETED
-
Intermittent Portal and Graft Purge in Living Donor Liver Transplantation
NCT02845154 ·Status: UNKNOWN ·Phase: NA
-
Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT
NCT04184401 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
NCT07172035 ·Status: RECRUITING
-
Early Postoperative CRRT After Liver Transplantation in ACLF Patients With Overt HE
NCT04317222 ·Status: UNKNOWN ·Phase: NA
-
Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation
NCT04252794 ·Status: COMPLETED ·Phase: NA
-
Selection Protocol for Liver Transplantation in Patients Aged Over 70 Years
NCT06382740 ·Status: RECRUITING
-
Dual Hypothermic Oxygenated Perfusion of DCD Liver Grafts in Preventing Biliary Complications After Transplantation
NCT02584283 ·Status: COMPLETED ·Phase: PHASE3
-
Purge Vs no Purge in Living Donor Liver Transplantation Recipients
NCT02540447 ·Status: COMPLETED ·Phase: NA
-
Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy
NCT05124041 ·Status: COMPLETED ·Phase: NA
-
Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization
NCT00698880 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effect of Terlipressin on Recovery of Liver Function After Hepatectomy
NCT04221672 ·Status: UNKNOWN ·Phase: PHASE3
-
Risk Factors and Outcome of Biliary Complications Following Adult Living Donor Liver Transplantation
NCT03789383 ·Status: RECRUITING
-
Impact of Splenic Artery Ligation in LDLT for Patients With Portal Hypertension
NCT04988100 ·Status: UNKNOWN ·Phase: NA
-
Terlipressin Administration in Patients Undergoing Major Liver Resection
NCT01921985 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease
NCT02366845 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Prognosis of Auxiliary Liver Transplantation
NCT07275008 ·Status: NOT_YET_RECRUITING
-
HOPE With Cytokine Filtration in Liver Transplantation (Cyto-HOPE)
NCT04203004 ·Status: UNKNOWN ·Phase: NA
-
TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
NCT02485184 ·Status: UNKNOWN ·Phase: NA
-
Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis
NCT02335580 ·Status: COMPLETED
-
Internal Jugular Vein Distensibility in Assessment of Fluid Responsiveness in Donors of Living Donor Liver Transplantation
NCT03391037 ·Status: COMPLETED
-
To Compare Relaxed Rotational Thromboelastometry Cut-offs With Standard Cut-offs for Guiding Blood Product Use Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure Patients
NCT05672589 ·Status: UNKNOWN ·Phase: NA
-
RESTORE Declined Livers Study
NCT04483102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA